Switch to:
More From Other Websites
Deutsche Bank's Take On Big Pharma: 3 Buys And A Hold Jun 23 2017
Biogen’s IMRALDI®, an Adalimumab Biosimilar Candidate Referencing Humira®, Granted Positive... Jun 23 2017
Biogen, Inc. – Value Analysis (NASDAQ:BIIB) : June 22, 2017 Jun 22 2017
Futures: These 2 Big Breakouts Highlight New Market Leadership Jun 22 2017
[$$] Pharma recovers composure as price concerns ease Jun 21 2017
Biotech Breakouts: Biogen Spinoff Bioverativ In Buy Zone Jun 21 2017
Amgen An Undervalued Industry Leader Jun 21 2017
Amgen: In Defense of A Pipeline Jun 21 2017
Biogen, Inc. breached its 50 day moving average in a Bullish Manner : BIIB-US : June 21, 2017 Jun 21 2017
Biogen to Report Second Quarter 2017 Financial Results and Strategic Update on July 25, 2017 Jun 20 2017
Updates on the Adcetris and Opdivo Combination Jun 20 2017
Biogen Appoints Ginger Gregory Executive Vice President, Chief Human Resources Officer Jun 20 2017
5 Most Profitable Big Pharma Stocks on the Market Right Now Jun 20 2017
US STOCKS-Wall St hits record highs on strong technology, health stocks Jun 19 2017
The Near-Term Setup For Biogen Has Positive Risk/Reward Written All Over It Jun 19 2017
US STOCKS-Wall St at record highs on technology, health stocks strength Jun 19 2017
Biogen's stock jumps after UBS boosts rating, price target Jun 19 2017
Picks of Steel Jun 19 2017
Biogen Upgraded at UBS on Alzheimer's Clinical Trial Progress Jun 19 2017
Biogen: "The Underperformance Stops Here" Jun 19 2017
Total Records: 116   Page:1 2 3 Next Page
40 per page ▾
10 20 25 30 50 100


Total Records: 116   Page:1 2 3 Next Page
40 per page ▾
10 20 25 30 50 100

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK